Press Releases Eli Lilly and Company Euronext Paris

Equities

LLY

US5324571083

Real-time Euronext Paris Other stock markets 11:05:35 2019-10-29 am EDT			5-day change	1st Jan Change
98 ^EUR	-1.01%		-.--%	+2.08%

08:13am	Roche reports positive early results in obesity drug trial	RE
Jul. 16	Aclaris Therapeutics Sells Olumiant Royalties, Milestone Payments From Eli Lilly	MT

Press Releases

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Neuroendocrine Tumors Pipeline 2024 \| Amgen, Eli Lilly and Company, GlaxoSmithKline, Hutchison Medipharma Limited, Ipsen, Seneca Therapeutics, Crinetics Pharmaceuticals, ADC Therapeutics, BeiGene	Jul. 12	AQ
Eli Lilly Finalizes Acquisition Agreement to Acquire Morphic for $3.2 Billion - InsideArbitrage	Jul. 10	AQ
Weight loss drug Zepbound outperforms Ozempic in new published study	Jul. 08	AQ
Lilly agrees $3.2b IBD acquisition	Jul. 08	AQ
Tesla, Archer Aviation rise; Eli Lilly falls, Tuesday, 7/2/2024	Jul. 02	AQ
TRexBio Announces Collaboration Partner Lilly Has Initiated a Phase 1 Study of TRB-051 for Autoimmune and Inflammatory Diseases	Jun. 27	AQ
Augustine Therapeutics announces EUR17 million Series A1 financing round	Jun. 27	AQ
Lilly collaborates with OpenAI to discover novel medicines to treat drug-resistant bacteria	Jun. 25	PR
Lilly Declares Third-Quarter 2024 Dividend	Jun. 24	PR
WHO and Eli Lilly caution patients against falling for fake versions of popular weight-loss drugs	Jun. 20	AQ
Eli Lilly and : Lilly Warns Patients About Counterfeit and Compounded Medicines Releases Open Letter and Takes Further Legal Action Against Counterfeit, Fake, Unsafe, and Untested Products	Jun. 20	PU
Eli Lilly and : An Open Letter From Eli Lilly and Company Regarding Certain Practices Related to Mounjaro® and Zepbound®	Jun. 20	PU
Lilly's tirzepatide was superior to placebo for MASH resolution, and more than half of patients achieved improvement in fibrosis at 52 weeks	Jun. 08	PR
Lilly announces departure of Anat Ashkenazi, chief financial officer	Jun. 05	PR
Eli Lilly and Company - Melissa Seymour to join Lilly as executive vice president of Global Quality	Jun. 05	AQ
Silo Pharma's (NASDAQ: SILO) Promising Developments and Key Insights for Traders and Investors	Jun. 04	AQ
Eli Lilly and : Asco Lilly Oncology Presentation	Jun. 03	PU
AKTIS ONCOLOGY NAMES TYLER BENEDUM, Ph.D., CHIEF TECHNICAL OFFICER	May. 31	AQ
Lilly, UNICEF expand support to help millions of young people at risk of noncommunicable diseases	May. 29	PR
NanoViricides (NNVC) Strengthens Drug Development Efforts with Calvert Labs Partnership and Announces Promising RSV Study Results	May. 29	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

David Ricks, CEO of Eli Lilly: A market of over a billion people

March 12, 2024 at 02:47 pm EDT